NYSE-listed ADC Therapeutics, a commercial-stage biotechnology company, has completed a series of strategic transactions in which it: Entered into a new US$175m senior secured term loan with funds of Owl…
NYSE-listed ADC Therapeutics, a commercial-stage biotechnology company, has completed a series of strategic transactions in which it: Entered into a new US$175m senior secured term loan with funds of Owl…
…
Rankings & Reports
M&A
Equity
Healthcare Investing Review
Healthcare Real Assets Report
Resources & Events
Resource Hub
Sector Events
Private Capital Conference
Real Assets Conference